CPClaire Louise Price

Claire Louise Price

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Claire Louise Price has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Interactive visualization of enzyme kinetics: a shiny app for biomedical, pharmacology, and biochemistry education

    by Claire L. Price, J. Gareth Noble, Aidan Seeley

    Students often find enzyme kinetics difficult because mathematical models can appear disconnected from biological meaning. The freely available Kinetics Analysis App was created to help address this challenge. Through interactive visualization of four classical kinetic models, learners are able to explore parameter estimation and model selection in real time. This web-based tool supports active learning, improves confidence in data interpretation, and provides an accessible approach for teaching quantitative concepts in biomedical and pharmacological sciences.

  • Open Access

    Visible through touch: open-source 3D-printed tools for inclusive microbiology education

    by Claire L. Price, Aidan Seeley, Hayley Pincott, Daniel J. Morse, Llinos G. Harris, J. Gareth Noble

    Microbiology education relies heavily on visual interpretation of microbe cultures, microscopy and assays, which can create barriers for blind and visually impaired learners. Inclusive teaching requires multimodal tactile approaches that make microbiology accessible to all students. This work presents two open-source browser-based web applications (the Agar Plate STL Generator and Microscope Slide to STL) designed to convert standard microbiological images into 3D-printable tactile models. Both tools use heightmap-based image processing to translate visual data into topographic 3D surfaces. Users can upload digital images of agar plates or microscope slides (e.g. in jpg format), adjust relief depth through an interactive interface and generate printable STL files without prior experience in computer-aided design or 3D printing. The resulting tactile models replicate spatial and morphological features of microbial growth and microscopy, enabling learners to ‘see through touch’. These tools enable independent participation by visually impaired students and promote multi-sensory engagement for all learners. Both applications and their source code are freely available under a Creative Commons Attribution–NonCommercial 4.0 licence via GitHub and Zenodo. Open-source tactile microbiology tools provide a scalable, inclusive means to bridge the accessibility gap in STEM education. By converting visual laboratory outputs into tangible models, these resources support universal design for learning and foster equitable participation in microbiology.


  • Open Access

    Visible Through Touch: Open-Source 3D-Printed Tools for Inclusive Microbiology Education

    by Claire Louise Price, Aidan Seeley, Hayley Pincott, Daniel J. Morse, Llinos G Harris, J. Gareth Noble

    Microbiology education relies heavily on visual interpretation of microbe cultures, microscopy, and assays, which can create barriers for blind and visually impaired learners. Inclusive teaching requires multimodal, tactile approaches that make microbiology accessible to all students. This work presents two open-source, browser-based web applications (the Agar Plate STL Generator and Microscope Slide to STL) designed to convert standard microbiological images into 3D-printable tactile models. Both tools use heightmap-based image processing to translate visual data into topographic 3D surfaces. Users can upload digital images of agar plates or microscope slides (e.g. in jpg format), adjust relief depth through an interactive interface, and generate printable STL files without prior experience in computer-aided design or 3D printing. The resulting tactile models replicate spatial and morphological features of microbial growth and microscopy, enabling learners to “see through touch”. These tools enable independent participation by visually impaired students and promote multisensory engagement for all learners. Both applications and their source code are freely available under a Creative Commons Attribution–NonCommercial 4.0 licence via GitHub and Zenodo. Open-source tactile microbiology tools provide a scalable, inclusive means to bridge the accessibility gap in STEM education. By converting visual laboratory outputs into tangible models, these resources support universal design for learning and foster equitable participation in microbiology.

  • Open Access

    Enmediating a platform, enabling fandom: Accessible creation tools and new methods of production for the Game Boy

    by Rhys James Jones, Claire Louise Price, Simeon Smith

    We explore the Game Boy as a case study in the enmediation of digital platforms, showing how accessible creation tools and shifting media ecologies have enabled fan-led innovation far beyond the console's original intended use. Long after Nintendo ceased commercial support for the Game Boy, fans have not only sustained its cultural relevance but have transformed it into a vibrant hub for music, gaming, and digital art production. Drawing on theories of remediation, enmediation, and media ecology, we argue that the Game Boy's unchanged physical form belies a radical transformation in its cultural and creative functions. Through tools like GB Studio and LSDJ, and practices such as chiptune performance, homebrew game development, and pixel art creation, fans have become enmediatory agents who challenge traditional power structures in platform production. This reconfiguration of the Game Boy's role within contemporary digital culture provides new insights into platform fandom, grassroots creativity, and the politics of obsolescence.

  • Open Access

    Visible Through Touch: Open-Source 3D-Printed Tools for Inclusive Microbiology Education

    by Claire Louise Price, Aidan Seeley, Hayley Pincott, Daniel J. Morse, Llinos G Harris, J. Gareth Noble

    Microbiology education relies heavily on visual interpretation of cultures, microscopy, and assays, which can create barriers for blind and visually impaired learners. Inclusive teaching requires multimodal, tactile approaches that make microbiology accessible to all students. This work presents two open-source, browser-based web applications (the Agar Plate STL Generator and Microscope Slide to STL) designed to convert standard microbiological images into 3D-printable tactile models. Both tools use heightmap-based image processing to translate visual data into topographic 3D surfaces. Users can upload images of agar plates or microscope slides, adjust relief depth through an interactive interface, and generate printable STL files without prior experience in computer-aided design or 3D printing. The resulting tactile models replicate spatial and morphological features of microbial growth and microscopy, enabling learners to “see through touch”. These tools help enable independent participation by visually impaired students and promote multisensory engagement for all learners. Both applications and their source code are freely available under a Creative Commons Attribution–NonCommercial 4.0 licence via GitHub and Zenodo. Open-source tactile microbiology tools provide a scalable, inclusive means to bridge the accessibility gap in STEM education. By converting visual laboratory outputs into tangible models, these resources support universal design for learning and foster equitable participation in microbiology.

  • Open Access

    Addressing Health Disparities: How Having a More Diverse Biomedical Workforce Can Contribute to Addressing Health Disparities in Communities that Are Often Underrepresented in the Healthcare System

    by Victoria Heath, Claire L. Price

    Health disparities that are seen in underserved and underrepresented communities are a pressing issue in healthcare. These disparities are embedded into our society through structural inequalities that lead to poorer health outcomes in those from minoritised communities. In its place as the heart of modern healthcare, the biomedical science workforce has the potential to play a crucial role in mitigating these disparities by fostering greater cultural competence, improving patient outcomes and driving innovative solutions. This study reviewed the current literature on the impact of diversity within the biomedical science workforce on health disparities in underserved communities. The review demonstrated where embedded inequities in healthcare lead to worse health outcomes for underserved communities. These disparities are found across healthcare education, diagnostic processes as well as within research and innovation, and this work uses the COVID-19 Pandemic as an example of where health disparities have significant consequences for the communities impacted. This review demonstrates that a diverse biomedical science workforce can not only contribute to better health outcomes, but also to inclusive research agendas and clinical studies by ensuring that research priorities are more representative of a broader population. A more diverse biomedical science workforce can serve as role models and mentors, inspiring the next-generation of biomedical scientists from underrepresented backgrounds creating a continuous cycle of inclusion and representation, helping to reduce health disparities over time. Therefore, a key strategy in promoting health equity is by increasing diversity in the biomedical science field. After review of current published works, the authors have proposed a list of recommendations that outline steps institutions, professional bodies and policymakers could take to a strategic and sustained commitment to improving biomedical science workforce diversity in an effort to reduce health disparities.


  • Open Access

    Novel Strategies for Preventing Fungal Infections—Outline

    by Damilola J. Agbadamashi, Claire L. Price

    Fungal infections are a significant global health challenge, causing approximately 3.8 million deaths annually, with immunocompromised populations particularly at risk. Traditional antifungal therapies, including azoles, echinocandins, and polyenes, face limitations due to rising antifungal resistance, toxicity, and inadequate treatment options. This review explores innovative strategies for preventing and managing fungal infections, such as vaccines, antifungal peptides, nanotechnology, probiotics, and immunotherapy. Vaccines offer promising avenues for long-term protection, despite difficulties in their development due to fungal complexity and immune evasion mechanisms. Antifungal peptides provide a novel class of agents with broad-spectrum activity and reduced resistance risk, whilst nanotechnology enables targeted, effective drug delivery systems. Probiotics show potential in preventing fungal infections, particularly vulvovaginal candidiasis, by maintaining microbial balance. Immunotherapy leverages immune system modulation to enhance antifungal defenses, and omics technologies deliver comprehensive insights into fungal biology, paving the way for novel therapeutic and vaccine targets. While these approaches hold immense promise, challenges such as cost, accessibility, and translational barriers remain. A coordinated effort among researchers, clinicians, and policymakers is critical to advancing these strategies and addressing the global burden of fungal infections effectively.


  • Open Access

    Novel Strategies for Preventing Fungal Infections Outline

    by Damilola Janet Agbadamashi, Claire Louise Price

    Fungal infections are a significant global health challenge, causing approximately 3.8 million deaths annually, with immunocompromised populations particularly at risk. Traditional antifungal therapies, including azoles, echinocandins, and polyenes, face limitations due to rising antifungal resistance, toxicity, and inadequate treatment options. This review explores innovative strategies for preventing and managing fungal infections, such as vaccines, antifungal peptides, nanotechnology, probiotics and immunotherapy. Vaccines offer promising avenues for long-term protection, despite difficulties in development due to fungal complexity and immune evasion mechanisms. Antifungal peptides provide a novel class of agents with broad-spectrum activity and reduced resistance risk, whilst nanotechnology enables targeted, effective drug delivery systems. Probiotics show potential in preventing fungal infections, particularly vulvovaginal candidiasis, by maintaining microbial balance. Immunotherapy leverages immune system modulation to enhance antifungal defences, and omics technologies deliver comprehensive insights into fungal biology, paving the way for novel therapeutic and vaccine targets. While these approaches hold immense promise, challenges such as cost, accessibility, and translational barriers remain. A coordinated effort among researchers, clinicians, and policymakers is critical to advancing these strategies and addressing the global burden of fungal infections effectively.

  • Open Access

    CYP168A1 from Pseudomonas aeruginosa may not be involved in the hydroxylation of medium chain-length fatty acids

    by Chiara Bonaldo, Nerissa E. Thomas, Claire Louise Price

    Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen and the main cause of chronic lung infections in patients with cystic fibrosis (CF). Its resistance to multiple antibiotics poses a significant challenge in eradicating the bacteria from CF’s patients airways. Consequently, the World Health Organization (WHO) has classified it as priority health concern, underscoring the urgent need to identify new antibiotic targets. While the function of cytochrome P450 (P450) enzymes in P. aeruginosa remains unclear, these enzymes are involved in fatty acid metabolism in Mycobacterium tuberculosis, a closely related bacterium, aiding its survival and growth in the lung. This suggests that P. aeruginosa P450 enzymes might contribute to CF airway colonization and the lung destruction by hydroxylating fatty acids in the lung surfactant. Previous research has demonstrated that CYP168A1, a P450 enzyme in P. aeruginosa, can biochemically hydroxylate fatty acids. To explore the biological role of CYP168A1, we monitored changes in gene expression after fatty acids exposure using RT-PCR. Our analyses revealed no change in CYP168A1 expression, suggesting that CYP168A1 is not involved in hydroxylation of medium-chain length fatty acids. Further knock-out analyses are essential to elucidate the biological role of CYP168A1, and its potential as an antimicrobial target against P. aeruginosa.

  • Open Access

    CYP168A1 from Pseudomonas aeruginosa may not be involved in the hydroxylation of medium chain-length fatty acids

    by Chiara Bonaldo, Nerissa E. Thomas, Claire Louise Price

    Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen and the main cause of chronic lung infections in patients with cystic fibrosis (CF). Its resistance to multiple antibiotics poses a significant challenge in eradicating the bacteria from CF’s patients airways. Consequently, the World Health Organization (WHO) has classified it as priority health concern, underscoring the urgent need to identify new antibiotic targets. While the function of cytochrome P450 (P450) enzymes in P. aeruginosa remains unclear, these enzymes are involved in fatty acid metabolism in Mycobacterium tuberculosis, a closely related bacterium, aiding its survival and growth in the lung. This suggests that P. aeruginosa P450 enzymes might contribute to CF airway colonization and the lung destruction by hydroxylating fatty acids in the lung surfactant. Previous research has demonstrated that CYP168A1, a P450 enzyme in P. aeruginosa, can biochemically hydroxylate fatty acids. To explore the biological role of CYP168A1, we monitored changes in gene expression after fatty acids exposure using RT-PCR. Our analyses revealed no change in CYP168A1 expression, suggesting that CYP168A1 is not involved in hydroxylation of medium-chain length fatty acids. Further knock-out analyses are essential to elucidate the biological role of CYP168A1, and its potential as an antimicrobial target against P. aeruginosa.